{"id":"W2320076910","doi":"10.1093/annonc/mdu193.1","title":"Phase 2 Double-Blind, Placebo–Controlled Trial of Dasatinib Added to Gemcitabine for Subjects with Locally-Advanced Pancreatic Cancer (LAPC)","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dasatinib; Gemcitabine; Internal medicine; Clinical endpoint; Pancreatic cancer; Oncology; Cancer; Progression-free survival; Performance status; Placebo; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy; Pathology; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001448196,0.002638038,0.004779714,0.0005074104,0.0006396994,0.001358684,0.00127372,0.002524156,0.01183869],"category_scores_gemma":[0.001731509,0.001275275,0.001859908,0.0004415386,0.001618254,0.001879847,0.0004872341,0.00469637,0.002402361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008554685,"about_ca_system_score_gemma":0.001413924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009306804,"about_ca_topic_score_gemma":0.00229907,"domain_scores_codex":[0.9994313,0.00022996,0.00003377968,0.000172845,0.00003284481,0.00009918406],"domain_scores_gemma":[0.9992781,0.0001748547,0.0001308338,0.00008081571,0.00006217381,0.0002732732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9854434,0.004830902,0.0001629701,0.0004235898,0.0004695394,0.00002071015,0.00003733963,0.0001578198,0.002038666,0.0000739728,0.0007045883,0.005636422],"study_design_scores_gemma":[0.9747909,0.02377472,0.0004874542,0.00001100359,0.0001350591,0.00001484897,0.00001220063,0.0001474261,0.0001894512,0.00007103544,0.0003565988,0.000009334125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739212,0.006321622,0.001643904,0.001621076,0.002006272,0.007411395,0.00271298,0.000465576,0.003896121],"genre_scores_gemma":[0.9747386,0.002906244,0.002618639,0.001833281,0.000657615,0.00771104,0.002120216,0.00006866859,0.007345702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01183869,"threshold_uncertainty_score":0.03960443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1196532496027519,"score_gpt":0.4648044448516966,"score_spread":0.3451511952489447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}